NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-λB signaling

Histiocytic sarcoma is an uncommon malignancy in both humans and veterinary species. Research exploring the pathogenesis of this disease is scarce; thus, diagnostic and therapeutic options for patients are limited. Recent publications have suggested a role for the NLR, NLRX1, in acting as a tumor su...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Coutermarsh-Ott, Sheryl, Simmons, Alysha, Capria, Vittoria, LeRoith, Tanya, Wilson, Justin E., Heid, Bettina, Philipson, Casandra W., Qin, Qizhi, Hontecillas-Magarzo, Raquel, Bassaganya-Riera, Josep, Ting, Jenny P-Y, Dervisis, Nikolaos, Allen, Irving C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5078078/
https://ncbi.nlm.nih.gov/pubmed/27105514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8861
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi